Pure Global
Disease / condition

Schizophrenia clinical trials

Free access to 2,119 studies·10+ countries·Updated daily248 recruiting
2,119
Total trials
10+
Countries
10+
Sponsors
248
Recruiting
By phase
N/A900
Phase 3328
Phase 4232
Phase 2213
Phase 1194
By status
Completed1,291
Recruiting248
Unknown247
Terminated119
Not yet recruit...111
Top countries
United States of America446
China229
Iran168
Japan129
United Kingdom80
Top sponsors
Johnson & Johnson ...52
Otsuka Pharmaceuti...47
AstraZeneca46
Shanghai Mental He...45
H. Lundbeck A/S32
Recent trials
Latest clinical trials for Schizophrenia
SLCTR_2013_008·Not ApplicableCompleted
Developing social skills, communication skills and self confidence through dance, drama and yoga in patients with long term mental illness at NIMH, Angoda
National Institute of Mental H...Sri Lanka
2015-001221-16
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
Janssen Cilag N.V./S.A
IRCT138904014236N1Completed
Effect of Topiramate in treatment of chronic schizophrenia
Mashad university of medical s...Iran
PHRR220921-004972·Phase 3Suspended
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Boehringer Ingelheim (Philippi...Australia Brazil Canada China Colombia Germany Greece Italy Japan Mexico New Zealand Norway Philippi
SLCTR_2010_004·Not ApplicableRecruiting
Effectiveness of metformin in reducing weight gain caused by antipsychotics
Faculty of MedicineSri Lanka
SLCTR_2020_024·Phase 2Recruiting
A long-term clinical study using Evenamide (orally taken new drug without masking its strength) to determine its safety, tolerability and efficacy in patients with treatment resistant schizophrenia, not befitting adequately from their current antipsychotic medication
Dr Ravi Anand/Newron Pharmaceu...India, Italy, Malaysia, Sri Lanka
NCT06397950Not yet recr...
Correlates of Fatigue in People With Schizophrenia
GCS CIPS
NCT06386588Not yet recr...
The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia
Massachusetts General HospitalUnited States of America
NCT06345963Not yet recr...
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
The University of Texas Health...United States of America
NCT06315972·Phase 2Not yet recr...
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity
LMU Klinikum
NCT06315283·Phase 1Recruiting
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
Teva Branded Pharmaceutical Pr...United States of America
NCT06301074·Phase 1Not yet recr...
The Phase I Study of HS-10509 in Chinese Adult Subjects
Jiangsu Hansoh Pharmaceutical ...China
NCT06276361·Phase 1Recruiting
Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia
Rovi Pharmaceuticals Laborator...Jordan
NCT06253546·Phase 1Recruiting
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
Teva Branded Pharmaceutical Pr...China
NCT06236451·Phase 4Not yet recr...
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
All India Institute of Medical...
NCT06236048Recruiting
Energetics and Glutamate in Schizophrenia
King's College LondonUnited Kingdom
NCT06231732Recruiting
The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study
Sir Run Run Shaw HospitalChina
NCT06245213·Phase 2Recruiting
A Study of ANAVEX3-71 in Adults With Schizophrenia
Anavex Life Sciences Corp.United States of America
NCT06155682Not yet recr...
TMS for Inhibition Enhancement in Schizophrenia
University of Maryland, Baltim...
NCT06142422Not yet recr...
Intermittent Theta Burst Stimulation of the Precuneus
GCS Ramsay Santé pour l'Enseig...France
View all 2,119 trials →
About this record

Access comprehensive clinical trial information for Schizophrenia through Pure Global AI's free database. This collection includes 2,119 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 248 trials are actively recruiting participants.

Research for Schizophrenia is being conducted in United States of America, China, Iran and 7+ other countries. Leading sponsors include Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and Otsuka Pharmaceutical Development & Commercialization, Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 2,119 clinical trials studying Schizophrenia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Otsuka Pharmaceutical Development & Commercialization, Inc., AstraZeneca, among others.